148 related articles for article (PubMed ID: 19410533)
1. Commonality but diversity in cancer gene fusions.
Rabbitts TH
Cell; 2009 May; 137(3):391-5. PubMed ID: 19410533
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic gene fusions in epithelial carcinomas.
Prensner JR; Chinnaiyan AM
Curr Opin Genet Dev; 2009 Feb; 19(1):82-91. PubMed ID: 19233641
[TBL] [Abstract][Full Text] [Related]
3. Morphologic features of carcinomas with recurrent gene fusions.
Qi M; Li Y; Liu J; Yang X; Wang L; Zhou Z; Han B
Adv Anat Pathol; 2012 Nov; 19(6):417-24. PubMed ID: 23060067
[TBL] [Abstract][Full Text] [Related]
4. Gene fusions find an ERG-way to tumor inflammation.
Martin SK; Kyprianou N
Cancer Biol Ther; 2011 Feb; 11(4):418-20. PubMed ID: 21248480
[No Abstract] [Full Text] [Related]
5. The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.
Shah RB; Chinnaiyan AM
Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877
[TBL] [Abstract][Full Text] [Related]
6. Evidence of recurrent gene fusions in common epithelial tumors.
Kumar-Sinha C; Tomlins SA; Chinnaiyan AM
Trends Mol Med; 2006 Nov; 12(11):529-36. PubMed ID: 17011825
[TBL] [Abstract][Full Text] [Related]
7. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
[TBL] [Abstract][Full Text] [Related]
8. Identification of recurrent fusion genes across multiple cancer types.
Yu YP; Liu P; Nelson J; Hamilton RL; Bhargava R; Michalopoulos G; Chen Q; Zhang J; Ma D; Pennathur A; Luketich J; Nalesnik M; Tseng G; Luo JH
Sci Rep; 2019 Jan; 9(1):1074. PubMed ID: 30705370
[TBL] [Abstract][Full Text] [Related]
9. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
French CA; Miyoshi I; Kubonishi I; Grier HE; Perez-Atayde AR; Fletcher JA
Cancer Res; 2003 Jan; 63(2):304-7. PubMed ID: 12543779
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal aberrations in solid tumors.
Chinnaiyan AM; Palanisamy N
Prog Mol Biol Transl Sci; 2010; 95():55-94. PubMed ID: 21075329
[TBL] [Abstract][Full Text] [Related]
11. TMPRSS2-ERG fusion as a marker of prostatic lineage in small-cell carcinoma.
Netto GJ
Histopathology; 2010 Oct; 57(4):633; author reply 633-4. PubMed ID: 20955388
[No Abstract] [Full Text] [Related]
12. Clinical applications of novel ERG immunohistochemistry in prostate cancer diagnosis and management.
Shah RB
Adv Anat Pathol; 2013 Mar; 20(2):117-24. PubMed ID: 23399797
[TBL] [Abstract][Full Text] [Related]
13. BreakTrans: uncovering the genomic architecture of gene fusions.
Chen K; Navin NE; Wang Y; Schmidt HK; Wallis JW; Niu B; Fan X; Zhao H; McLellan MD; Hoadley KA; Mardis ER; Ley TJ; Perou CM; Wilson RK; Ding L
Genome Biol; 2013 Aug; 14(8):R87. PubMed ID: 23972288
[TBL] [Abstract][Full Text] [Related]
14. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
15. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement.
Yoshimoto M; Joshua AM; Chilton-Macneill S; Bayani J; Selvarajah S; Evans AJ; Zielenska M; Squire JA
Neoplasia; 2006 Jun; 8(6):465-9. PubMed ID: 16820092
[TBL] [Abstract][Full Text] [Related]
16. Protocols for Studies on TMPRSS2/ERG in Prostate Cancer.
Pakula H; Linn DE; Schmidt DR; Van Gorsel M; Vander Heiden MG; Li Z
Methods Mol Biol; 2018; 1786():131-151. PubMed ID: 29786791
[TBL] [Abstract][Full Text] [Related]
17. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
Gao Q; Liang WW; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao WW; Reynolds SM; Wyczalkowski MA; Yao L; Yu L; Sun SQ; ; ; Chen K; Lazar AJ; Fields RC; Wendl MC; Van Tine BA; Vij R; Chen F; Nykter M; Shmulevich I; Ding L
Cell Rep; 2018 Apr; 23(1):227-238.e3. PubMed ID: 29617662
[TBL] [Abstract][Full Text] [Related]
18. [Chromosomal rearrangements and fusion genes in carcinoma].
Massard C; Auger N; Lacroix L; Bénard J
Bull Cancer; 2011 Dec; 98(12):1395-401. PubMed ID: 22172776
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling targeting chromosomes for tumor classification and prediction of clinical behavior.
Lu YJ; Williamson D; Wang R; Summersgill B; Rodriguez S; Rogers S; Pritchard-Jones K; Campbell C; Shipley J
Genes Chromosomes Cancer; 2003 Nov; 38(3):207-14. PubMed ID: 14506694
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Human-Similar Gene Fusions in Canine Cancers.
Ulvé R; Rault M; Bahin M; Lagoutte L; Abadie J; De Brito C; Coindre JM; Botherel N; Rousseau A; Wucher V; Cadieu E; Thieblemont C; Hitte C; Cornevin L; Cabillic F; Bachelot L; Gilot D; Hennuy B; Guillaudeux T; Le Goff A; Derrien T; Hédan B; André C
Cancer Res; 2017 Nov; 77(21):5721-5727. PubMed ID: 28883003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]